Cna Financial Corp Guardant Health, Inc. Transaction History

Cna Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$48.25 - $100.49 $141,276 - $294,234	-2,928 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $717,521 - $1.01 Million	-5,648 Reduced 65.86%	2,928 $447,000
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $68,972 - $93,791	-690 Reduced 7.45%	8,576 $1.11 Million
Q3 2020 Nov 12, 2020	SELL	$80.32 - $111.8 $171,242 - $238,357	-2,132 Reduced 18.71%	9,266 $1.04 Million
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $689,465 - $1.11 Million	11,398 New	11,398 $925,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.